SDZ.S (SDZ.S) News
Track canonical SquawkNews coverage tagged to SDZ.S, SDZ.S. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
BUZZ — Sandoz seen rising after it secures Canada approval for generic GLP — 1 shot
* Shares in Sandoz are indicated to rise 3% pre-market after Swiss generic drugmaker received regulatory approval for its generic semaglutide to treat type-2 diabetes in Canada * The injection is a generic version of Nov
EQUITY | Sep 18, 2026, 06:42 AM UTC
L
BRIEF — Sandoz Adds Emicizumab Biosimilar In Mabxience Deal
Sept 18 (Reuters) — SANDOZ GROUP AG: Sandoz Announces Collaboration With Mabxience To Expand Patient Access To Life-enhancing Biosimilar Medicines Agrees Emicizumab Biosimilar In $5.70 Billion Market; First Haemophilia B
NEWS | Sep 18, 2026, 05:22 AM UTC
L
Sandoz partners with mAbxience to develop emicizumab biosimilar###
Sandoz signed a licensing, development, manufacturing, commercialisation deal with mAbxience for a proposed emicizumab biosimilar. Agreement gives Sandoz exclusive global commercialisation rights, excluding Argentina, Ur
EARNINGS | Sep 18, 2026, 05:17 AM UTC
L
Sandoz announces collaboration with mAbxience to expand patient access to life — enhancing biosimilar medicines
Sandoz Group AG / Key word(s): Agreement Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines 18.09.2026 / 07:15 CET/CEST ═════════════════════════════════════════
EARNINGS | Sep 18, 2026, 05:17 AM UTC
H
BRIEF — Sandoz Gets Canada Approval For Generic Semaglutide
Sept 18 (Reuters) — SANDOZ GROUP AG: Sandoz Receives Regulatory Approval For Generic Semaglutide In Canada, Paving Way To Expand Patient Access To Key Glp-1 Medicine Receives Regulatory Approval For Generic Semaglutide I
NEWS | Sep 18, 2026, 05:07 AM UTC
H
Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP — 1 medicine
Sandoz Group AG / Key word(s): Regulatory Approval Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP-1 medicine 18-Sep-2026 / 07:00 CET/CEST Release of
EARNINGS | Sep 18, 2026, 05:02 AM UTC
L
Sandoz wins Health Canada approval for generic semaglutide injection
Health Canada granted marketing authorization for Sandoz Semaglutide, a generic version of Novo Nordisk’s Ozempic. Approval covers once-weekly subcutaneous use in adults with type 2 diabetes to improve glycemic control.
NEWS | Sep 18, 2026, 05:02 AM UTC